Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 956 of 1,261

  1. US 7994326

    Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  2. US 7994217

    Prenatal multivitamin/multimineral supplement

    Xanodyne Pharmaceuticals, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  3. US 7994139

    Antiviral therapeutic agents

    BioCryst Pharmaceuticals, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  4. US 7993921

    Cell cycle regulation and differentiation

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  5. US 7994193

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  6. US 7994183

    Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  7. US 7994307

    RNAi modulation of the BCR-ABL fusion gene and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  8. US 7994209

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  9. US 7994166

    Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain

    Vertex Pharmaceuticals Incorporated · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  10. US 7994205

    Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  11. US 7994360

    Benzofuran compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  12. US 7994132

    Peptides for treatment of scleroderma

    The Regents of the University of California · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  13. US 7994313

    Unsolvated benzodiazepine compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  14. US 7988971

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  15. US 7988967

    High affinity human antibodies to human nerve growth factor

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  16. US 7989456

    Pyrazine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  17. US 7989473

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  18. US 7988956

    Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

    Nektar Therapeutics · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  19. US 7989445

    Thienopyrimidone compound

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  20. US 7989448

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  21. US 7988958

    Enterococcus and Streptococcus strains and bacteriocins

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  22. US 7988977

    Modified live Aeromonas hydrophila vaccine for aquatic animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  23. US 7988685

    Hydrogel compositions, devices, and microscale components

    Regents of the University of Minnesota · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  24. US 7989481

    Indane derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.